V. Stojanović

发表

Myotonic dystrophy type 1

S. Peric, V. Stojanović, I. Basta, 2015 .

Routine echocardiography in patients with myotonic dystrophy type 1

S. Peric, S. Raspopović, V. Stojanović, 2017, Journal of the Chinese Medical Association : JCMA.

Cardiologic predictors of sudden death in patients with myotonic dystrophy type 1

S. Peric, D. Lavrnić, V. Stojanović, 2013, Journal of Clinical Neuroscience.

Myopathic changes detected by quantitative electromyography in patients with MuSK and AChR positive myasthenia gravis

D. Lavrnić, V. Stojanović, I. Basta, 2016, Journal of Clinical Neuroscience.

A novel recessive TTN founder variant is a common cause of distal myopathy in the Serbian population

D. MacArthur, M. Lek, Hanns Lochmüller, 2017, European Journal of Human Genetics.

Update of the pompe disease mutation database with 60 novel GAA sequence variants and additional studies on the functional effect of 34 previously reported variants

S. Marie, W. Robberecht, B. Engelen, 2012, Human mutation.

The features of myasthenia gravis with autoantibodies to MuSK

M. D. de Baets, M. Losen, A. Vujic, 2005, Journal of Neurology, Neurosurgery & Psychiatry.

Peripheral neuropathy in patients with myotonic dystrophy type 1

A. Kačar, D. Lavrnić, V. Stojanović, 2013, Neurological research.

MuSK myasthenia gravis and Lambert–Eaton myasthenic syndrome in the same patient

M. Losen, P. Martinez-Martinez, D. Lavrnić, 2012, Clinical neurology and neurosurgery (Dutch-Flemish ed. Print).

Is hyperlipidemia correlated with longer survival in patients with amyotrophic lateral sclerosis?

Velimir Dedic, D. Lavrnić, Svetlana I Kostic Dedic, 2012, Neurological research.

Hereditary persistent distal cramps1

V. Stojanović, A. Jušić, S. Dogan, 1972, Journal of neurology, neurosurgery, and psychiatry.

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

J. Statland, M. Pasnoor, J. Verschuuren, 2021, The Lancet Neurology.

[Myasthenia gravis--a disease with variable impact on working capability].

D. Lavrnić, S. Apostolski, V. Stojanović, 2007, Srpski arhiv za celokupno lekarstvo.

The presence of dysautonomia in different subgroups of myasthenia gravis patients

D. Lavrnić, V. Stojanović, S. Popović, 2014, Journal of Neurology.

Fatigue in myotonic dystrophy type 1: a seven-year prospective study

I. Bozovic, V. Stojanović, I. Basta, 2019, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

Cerebrospinal fluid biomarkers of neurodegeneration in patients with juvenile and classic myotonic dystrophy type 1

V. Kostic, G. Mandić-Stojmenović, E. Stefanova, 2013, Journal of the Neurological Sciences.

Identification of GAA variants through whole exome sequencing targeted to a cohort of 606 patients with unexplained limb-girdle muscle weakness

D. MacArthur, M. Lek, K. Claeys, 2017, Orphanet Journal of Rare Diseases.

The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis

D. Lavrnić, S. Lavrnić, V. Stojanović, 2013, Clinical neurology and neurosurgery (Dutch-Flemish ed. Print).

Electrophysiological profile of the patients with MuSK positive myasthenia gravis

D. Lavrnić, V. Stojanović, I. Basta, 2014, Neurological research.

Influence of multisystemic affection on health-related quality of life in patients with myotonic dystrophy type 1

D. Lavrnić, V. Stojanović, I. Basta, 2013, Clinical Neurology and Neurosurgery.

Physical and Mental Aspects of Quality of Life in Patients With Charcot-Marie-Tooth Disease Type 1A

A. Kačar, I. Bozovic, V. Stojanović, 2022, Frontiers in Neurology.

Quality of life in patients with myotonic dystrophy type 2

D. Lavrnić, V. Stojanović, M. Vujnić, 2016, Journal of the Neurological Sciences.

Brain positron emission tomography in patients with myotonic dystrophy type 1 and type 2

V. Stojanović, I. Basta, Biljana Salak-Djokic, 2017, Journal of the Neurological Sciences.

High frequency of DQB1*05 and absolute absence of DRB1*13 in muscle‐specific tyrosine kinase positive myasthenia gravis

D. Lavrnić, V. Stojanović, I. Basta, 2015, European journal of neurology.

Targeted Next Generation Sequencing Approach Towards Improving Genetic Diagnosis of Limb Girdle Muscular Dystrophy

M. Lek, K. Claeys, D. Macarthur, 2018 .

FAMILIAL OCCURRENCE OF AUTOIMMUNE MYASTHENIA GRAVIS WITH DIFFERENT ANTIBODY SPECIFICITY

J. Verschuuren, M. Losen, W. Verduyn, 2008, Neurology.